APT Medical's (SHA:688617) attributable profit rose 22% to 820.6 million yuan in 2025 from 673.2 million yuan in 2024, according to a Friday filing with the Shanghai bourse.
Earnings per share at the medical device maker increased 21% to 5.82 yuan from 4.80 yuan in the previous year.
Operating income grew 25% year over year to 2.58 billion yuan from 2.07 billion yuan.
Shares surged 7% during morning trading on Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.